Literature DB >> 10755803

Managing insomnia in the primary care setting: raising the issues.

G S Richardson1.   

Abstract

The optimal management of insomnia in the primary care setting should be viewed as a public health problem that will require specific attention. Important recent strides in the understanding of insomnia, its consequences, and its treatment do not always provide a basis for management strategies in a setting with distinct practical limitations. A somewhat different research focus will be needed if the scientific advances are to be translated into practical improvements in therapy. In primary care today, multiple agendas compete for the physician's time. Therefore, it is necessary to view diagnosis and management in terms of both what is efficient and what is optimally effective. Much can be learned from experience with medical risk factors of broad prevalence, such as hypercholesterolemia and hypertension. Large outcome trials demonstrating the benefits of drug therapy were required before pharmacologic management became standard care in the primary care setting. For insomnia, specific issues that must be addressed include the components of diagnosis that will guide therapy and affect prognosis. How can the 10% of adults with insomnia in the primary care practice be subdivided to identify those most in need of therapy? Stated another way, what are the features of insomnia that predict risk? Is duration important? Severity? Frequency? Which treatments are most effective? Which are most efficient in terms of the time required of patient and practitioner? Do treatments for insomnia produce patient satisfaction? Do they prevent adverse outcomes, such as depression and automobile accidents? Studies are now addressing many of these questions. In selecting research priorities, however, the practical application of this information in the clinical setting is important if the ultimate goal is to reduce the number of patients suffering from insomnia and its consequences.

Entities:  

Mesh:

Year:  2000        PMID: 10755803

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  6 in total

1.  Quality measures for the care of patients with insomnia.

Authors:  Jack D Edinger; Daniel J Buysse; Ludmila Deriy; Anne Germain; Daniel S Lewin; Jason C Ong; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

2.  Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.

Authors:  Kuo-Hsuan Chung; Chung-Yi Li; Shu-Yu Kuo; Trevor Sithole; Wen-Wei Liu; Min-Huey Chung
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

3.  Medications for the Treatment of Sleep Disorders: An Overview.

Authors:  J F Pagel; Bennett L. Parnes
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2001-06

4.  Consensus on drug treatment, definition and diagnosis for insomnia.

Authors:  E Estivill; A Bové; D García-Borreguero; J Gibert; J Paniagua; G Pin; F J Puertas; R Cilveti
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

5.  'As-needed' prescription of zolpidem for insomnia in routine general practice.

Authors:  Patrick Lévy; Marie-Anne Massuel; Daniel A Gérard
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

Review 6.  Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment.

Authors:  Hong Fang; Sheng Tu; Jifang Sheng; Anwen Shao
Journal:  J Cell Mol Med       Date:  2019-02-07       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.